Nektar Therapeutics

Address: 455 Mission Bay Boulevard South

Sponsor Overview

assignment

Specializations

Autoimmune Hair Loss

Nektar Therapeutics is involved in clinical research for alopecia areata, with a focus on severe to very severe disease and the restoration of scalp hair growth.

Severe alopecia areata
Hair loss reduction
Immune-mediated follicle disease

This area reflects interest in therapies aimed at modifying the underlying immune dysregulation associated with patchy and extensive hair loss.

Inflammatory Skin Disease

The sponsor also supports research in atopic dermatitis, including adult patients with moderate-to-severe disease and persistent inflammatory skin symptoms.

Moderate-to-severe atopic dermatitis
Skin inflammation
Eczema symptom control

Clinical activity in this field centers on improving disease burden in biologic-naive patients with active eczema.

Immune-Mediated Therapeutics

Across both programs, Nektar Therapeutics is engaged in research targeting immune-mediated disorders with relevance to dermatologic autoimmunity and chronic inflammation.

Immune pathway modulation
Dermatology-focused immunotherapy
Chronic inflammatory conditions

The therapeutic emphasis spans conditions where altered immune signaling contributes to persistent skin and hair follicle disease.

Trial Name	Country	Status
Efficacy and Safety Evaluation of Rezpegaldesleukin in Biologic-Naive Adults with Moderate-to-Severe Atopic Dermatitis: A Phase 2b Randomized, Double-Blind, Placebo-Controlled Trial	Bulgaria Croatia Czechia Germany Hungary Poland Spain	Not Recruiting
Efficacy and Safety Evaluation of Rezpegaldesleukin in Severe to Very Severe Alopecia Areata: A Phase 2B Randomized, Double-Blind, Placebo-Controlled Study	Poland	Not Recruiting